At present, the majority of patients with type 1 diabetes mellitus do not achieve the recommended glycemic control goals to reduce the risk of acute and chronic complications. Hybrid closed-loop systems or automated insulin infusion systems emerged as an opportunity to improve metabolic control, quality of life and reduce the psychosocial impact of type 1 diabetes. This article analyzes the evidence regarding their effectiveness and safety, the challenges they pose and best practices to optimize results when implemented in clinical practice.
Keywords: Asa cerrada; Automated delivery systems; Closed-loop; Diabetes mellitus tipo 1; Sistemas de infusión automatizada; Tratamiento; Treatment; Type 1 diabetes mellitus.
Copyright © 2024. Published by Elsevier España, S.L.U.